Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Antibody”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00589316
What this trial is testing

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+7 more
Fred Hutchinson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01008982
What this trial is testing

Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
University of Udine 15
Not applicableStudy completedNCT02073526
What this trial is testing

Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Oslo University Hospital 1,230
Large-scale testing (Phase 3)Looking for participantsNCT06846385
What this trial is testing

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd 160
Early research (Phase 1)Study completedNCT00582985
What this trial is testing

Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer

Who this might be right for
CancerNeoplasm Metastasis
Tracon Pharmaceuticals Inc. 51
Not applicableEnded earlyNCT00828620
What this trial is testing

Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project

Who this might be right for
Metastatic Colorectal Cancer
Universitaire Ziekenhuizen KU Leuven 21
Testing effectiveness (Phase 2)Study completedNCT04351243
What this trial is testing

Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

Who this might be right for
COVID-19
Kinevant Sciences GmbH 227
Early research (Phase 1)Study completedNCT01166490
What this trial is testing

Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

Who this might be right for
Gastric NeoplasmsPancreatic Neoplasms
Seagen Inc. 51
Large-scale testing (Phase 3)Study completedNCT00002968
What this trial is testing

Edrecolomab in Treating Patients With Stage II Colon Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonSignet Ring Adenocarcinoma of the ColonStage IIA Colon Cancer+2 more
National Cancer Institute (NCI) 2,100
Testing effectiveness (Phase 2)WithdrawnNCT06245291
What this trial is testing

Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Arbutus Biopharma Corporation
Early research (Phase 1)Study completedNCT01660360
What this trial is testing

Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic Cancer
PharmAbcine 26
Early research (Phase 1)Study completedNCT01727778
What this trial is testing

Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Drug Safety
Patrys Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT03223610
What this trial is testing

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Who this might be right for
LymphomaNon-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma+1 more
National Cancer Institute (NCI) 155
Large-scale testing (Phase 3)Looking for participantsNCT07321093
What this trial is testing

The Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Biocad 292
Testing effectiveness (Phase 2)Study completedNCT00657189
What this trial is testing

Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus

Who this might be right for
Lupus Erythematosus, SystemicLupus
MedImmune LLC 87
Very early researchUnknownNCT06360250
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation

Who this might be right for
Clostridium Tetanus
Changchun BCHT Biotechnology Co. 190
Testing effectiveness (Phase 2)Study completedNCT00142415
What this trial is testing

Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Ludwig Institute for Cancer Research 26
Testing effectiveness (Phase 2)UnknownNCT04749485
What this trial is testing

HX008 for the Treatment of Patients With Malignant Melanoma

Who this might be right for
Melanoma
Taizhou Hanzhong biomedical co. LTD 119
Large-scale testing (Phase 3)Study completedNCT03430297
What this trial is testing

A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma

Who this might be right for
Metastatic MelanomaUnresectable Melanoma
Shanghai Junshi Bioscience Co., Ltd. 256
Testing effectiveness (Phase 2)UnknownNCT04191343
What this trial is testing

Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen

Who this might be right for
Advanced Biliary Tract Tumors
Zhejiang Cancer Hospital 20
Next Page